1. Home
  2. UBCP vs BEAT Comparison

UBCP vs BEAT Comparison

Compare UBCP & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UBCP

United Bancorp Inc.

HOLD

Current Price

$14.32

Market Cap

85.4M

Sector

Finance

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$2.46

Market Cap

84.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
UBCP
BEAT
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
85.4M
84.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UBCP
BEAT
Price
$14.32
$2.46
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.75
AVG Volume (30 Days)
8.7K
32.1M
Earning Date
02-06-2026
11-13-2025
Dividend Yield
6.52%
N/A
EPS Growth
N/A
N/A
EPS
1.31
N/A
Revenue
$30,516,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.59
N/A
P/E Ratio
$10.95
N/A
Revenue Growth
4.40
N/A
52 Week Low
$12.25
$0.54
52 Week High
$15.64
$4.00

Technical Indicators

Market Signals
Indicator
UBCP
BEAT
Relative Strength Index (RSI) 58.07 57.52
Support Level $14.02 $2.50
Resistance Level $14.39 $3.18
Average True Range (ATR) 0.50 0.53
MACD 0.01 -0.03
Stochastic Oscillator 67.28 23.28

Price Performance

Historical Comparison
UBCP
BEAT

About UBCP United Bancorp Inc.

United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. Through its subsidiary (Unified Bank), the company provides a broad range of banking and financial services, which includes accepting demand, savings, and time deposits and granting commercial, real estate, and consumer loans. It serves customers in Belmont, Harrison, Jefferson, Tuscarawas, Carroll, Athens, Hocking, and Fairfield counties and the surrounding localities. The bank also operates in Marshall County West Virginia.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: